Lifecore Biomedical, Inc.
LFCR
Rank in Stocks
#15832
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an... Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Share Price
$6.37
Last synced: 2026-11-09
Market Cap
$241.46M
Change (1 day)
0.16%
Change (1 year)
-17.70%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lifecore Biomedical, Inc. (LFCR)
Category
Healthcare
Operating Margin for Lifecore Biomedical, Inc. (LFCR)
Operating Margin as of November 2026 TTM: -2.12%
According to Lifecore Biomedical, Inc.'s latest financial reports, its current operating margin (TTM) is -2.12%. At the end of 2025 the company had an operating margin of -0.97%.
Operating Margin history for Lifecore Biomedical, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2.12% | 118.56% |
| 2025 | -0.97% | -85.94% |
| 2024 | -6.90% | -67.31% |
| 2023 | -21.11% | 99.15% |
| 2022 | -10.60% | 21.14% |
| 2021 | -8.75% | -45.89% |
| 2020 | -16.17% | 1,022.92% |
| 2019 | -1.44% | -163.72% |
| 2018 | 2.26% | -22.34% |
| 2017 | 2.91% | -179.51% |
| 2016 | -3.66% | -207.02% |
| 2015 | 3.42% | -19.15% |
| 2014 | 4.23% | -24.87% |
| 2013 | 5.63% | 22.66% |
| 2012 | 4.59% | 58.28% |
| 2011 | 2.90% | -40.94% |
| 2010 | 4.91% | -8.05% |
| 2009 | 5.34% | -16.04% |
| 2008 | 6.36% | -55.93% |
| 2007 | 14.43% | 270.95% |
| 2006 | 3.89% | 32.76% |
| 2005 | 2.93% | 38.86% |
| 2004 | 2.11% | 0.00% |
| 2003 | 0.00% | -100.00% |
| 2002 | 0.69% | -149.64% |
| 2001 | -1.39% | 1,290.00% |
| 2000 | -0.10% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -109.16% |
DE
|
|
| 19.68% | -109.28% |
DE
|
|
| 13.26% | -106.25% |
JP
|
|
| 17.08% | -108.06% |
CH
|
|
| 14.92% | -107.04% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Lifecore Biomedical, Inc.'s operating margin
What is Lifecore Biomedical, Inc.'s operating margin?
Lifecore Biomedical, Inc.'s operating margin is -2.12%, as of Nov 2026.
What was Lifecore Biomedical, Inc.'s operating margin in 2025?
In 2025, Lifecore Biomedical, Inc.'s operating margin was -0.97%, compared with -6.90% in 2024.
How has Lifecore Biomedical, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Lifecore Biomedical, Inc.'s operating margin was highest in 2025 (-0.97%) and lowest in 2023 (-21.11%).
How does Lifecore Biomedical, Inc.'s operating margin compare with similar companies?
Lifecore Biomedical, Inc.'s operating margin (-2.12%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.